Concepedia

Ryota Shimada

RS

3

Publications

78

Citations

3

H-Index

2018

Active since

Affiliations

Tokyo University of Pharmacy and Life Sciences(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Josai University

Ryota Shimada is an author at Tokyo University of Pharmacy and Life Sciences specializing in glioma, high-grade gliomas, and neuro-oncology.

Top concepts

Publications per year

2018–2021

3

Publications

3

Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87

Lingyu Han, Bo Yuan, Ryota Shimada et al. · International Journal of Oncology · 2018 · 35 citations · Full text

, , +17

Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87

Bo Yuan, Ryota Shimada, Kang Xu et al. · Chemico-Biological Interactions · 2019 · 33 citations

, , +9

Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines

Bo Yuan, Kang Xu, Ryota Shimada et al. · Frontiers in Oncology · 2021 · 10 citations · Full text

Rows per page

1–3 of 3